AE O'Donnell - New England Journal of Medicine, 2022 - Mass Medical Soc
Bronchiectasis — A Clinical Review | New England Journal of Medicine Skip to main content The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Background Bronchiectasis is a heterogeneous, neglected disease with few multicentre studies exploring the causes, severity, microbiology, and treatment of the disease across …
GB Migliori, FM Marx, N Ambrosino… - … of Tuberculosis and …, 2021 - ingentaconnect.com
BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance …
S Aliberti, PC Goeminne, AE O'Donnell… - The Lancet …, 2022 - thelancet.com
Bronchiectasis refers to both a clinical disease and a radiological appearance that has multiple causes and can be associated with a range of conditions. Disease heterogeneity …
AB Chang, R Fortescue, K Grimwood… - European …, 2021 - Eur Respiratory Soc
There is increasing awareness of bronchiectasis in children and adolescents, a chronic pulmonary disorder associated with poor quality of life for the child/adolescent and their …
An estimated 58 million people have survived tuberculosis since 2000, yet many of them will suffer from post-tuberculosis lung disease (PTLD). PTLD results from a complex interplay …
Bronchiectasis is characterised by pathological dilation of the airways. More specifically, the radiographic demonstration of airway enlargement is the common feature of a …
Rationale: Bronchiectasis is classically considered a neutrophilic disorder, but eosinophilic subtypes have recently been described. Objectives: To use multiple datasets available …
HR Keir, A Shoemark, AJ Dicker, L Perea… - The lancet Respiratory …, 2021 - thelancet.com
Background Bronchiectasis is predominantly a neutrophilic inflammatory disease. There are no established therapies that directly target neutrophilic inflammation because little is …